Navigation Links
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
Date:6/14/2013

NEW YORK, June 14, 2013 /PRNewswire/ --

Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), and ImmunoGen, Inc. (NASDAQ: IMGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Alexion Pharmaceuticals, Inc. Research Report

On June 5, 2013, Alexion Pharmaceuticals, Inc. (Alexion) announced that the results of trials published in The New England Journal of Medicine (NEJM) showed that chronic Soliris (eculizumab) therapy is effective in the treatment of patients with atypical hemolytic uremic syndrome (aHUS), a genetic, life-long, ultra-rare disease associated with vital organ failure and premature death. According to results of two pivotal studies published in the NEJM, chronic Soliris treatment substantially inhibits systemic complement-mediated thrombotic microangiopathy (TMA), decreases the need for TMA-related intervention, and results in significant and sustained improvement in platelet count. It also increasingly improves renal function across patient groups over time, and is associated with substantial kidney recovery in patients with aHUS. Soliris was approved for the treatment of patients with aHUS in the US, Europe, and other countries based on data from the two prospective studies published in NEJM. The Full Research Report on Alexion Pharmaceuticals, Inc. - includin
'/>"/>

SOURCE Wall Street Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
4. Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
5. Net Medical Xpress Q3 Revenue Up 34% With Ongoing Launch of New Telemedicine Services
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Microfabrica To Introduce Educational Series For Design Engineers Challenged With Ongoing Drive To Miniaturization
8. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
9. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
10. Pfizer Identifies Synexus South African Clinical Research Sites as INSPIRE Sites - First in Africa
11. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Hitachi ... generation of OASIS *    at ECR 2015 ... power will set a benchmark for patient-centric care. The ... prevent delays whilst optimizing workflow management and costs. OASIS ... and safety for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, ...
(Date:3/5/2015)... 5, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, announced today that Atlanta ... hospitals for spinal cord injury and brain injury, has ... AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients with ... The Phase 1/2a trial follows the ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4Ascendis Pharma to Present at ENDO 2015 2
... Medicare expands a controversial "competitive" bidding program for home medical ... have gone on record to oppose that program citing reduced ... impact on local jobs. "There,s a reason why ... economists and auction experts , and 145 members of ...
... 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United ... and affiliated ambulatory clinics, today announced its participation in ... Global Emerging Markets One-on-One Conference, to be held September ...
Cached Medicine Technology:Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 3Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 4Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 5Chindex International, Inc. Announces Participation in Upcoming Investor Conferences 2
(Date:3/6/2015)... 06, 2015 FCPX developers have ... Film Studios. , “Pro3rd Hue is a lower 3rd pack ... of Pixel Film Studios. “Blurring the line between professional and ... Hue is a set of 30 customizable lower third presets ... Pro3rd Hue, FCPX users can complement any design with a ...
(Date:3/6/2015)... March 06, 2015 The producers of ... air dates for Spokane, Washington and vicinity. This is a ... shop and dine, and many outdoor activities. It is also ... local economy. Six major hospitals call the city home and ... border. The medically-focused cable TV program will be broadcast on ...
(Date:3/6/2015)... Fluid Running® Owner, Jennifer Conroyd, an ... Fluid Running® method 3 years ago when ... She hit upon the trifecta of combining matched-bpm music, ... maximum-resistance, deep water running technique. She not only completed ... running workout that made the experience both enjoyable and ...
(Date:3/6/2015)... Diego, CA (PRWEB) March 06, 2015 ... findings continue to be discussed, Ford & Associates Nationwide ... of a January 2015 filed lawsuit: Verduzco v. Daiichi ... Northern District of California. , “In light of ... who have used Benicar to evaluate and explore the ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve ... . These dates include the following activities:, ... October 6: Conference Day 1, ending with a ... Day 2, ending with Local Entertainment and Dinner , ... other Materials Meetings , October 9-10: Textiles in ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2
... from the American Heart Association, DALLAS, Oct. 9 ... can play havoc with a health regimen.,The American Heart ... habits play an important part of any holiday celebration. ... Year,s resolution to join Start!, the American Heart,Association,s worksite ...
... and Sub-ablative Treatments, YOKNEAM, Israel, Oct. ... laser and light-based devices for medical and ... a comprehensive,portfolio of fractional CO2 laser skin ... The Bridge Therapy portfolio includes,PigmentFX, ActiveFX, DeepFX ...
... Oct. 8 Digital Info,Security Company (Pink Sheets: DGIF) ... into a strategic partnership for technology product,marketing and sales ... partnership will allow DGIF to expand the reach of ... offer a more complete product suite to its,customers and ...
... brain well connected to other areas, researchers successfully delivered ... of gene therapy. If these results in animals can ... method for gene therapy to treat a host of ... Tay-Sachs disease. , Researchers from The Childrens Hospital of ...
... Oct. 8 QMed, Inc. (Nasdaq:,QMED) today announced ... 2007. Revenue for the three-month period increased to ... This revenue includes,amounts for the disease management segment ... August 31, 2007 and 2006, respectively. On a,sequential ...
... Wash., Oct. 8 - The Washington,State Veterinary Medical ... Burggren, a veterinarian with Olympia Pet,Emergency in Lacey. ... Burggren received his award in recognition of his ... graduate of Washington,State University,s College of Veterinary Medicine, ...
Cached Medicine News:Health News:Have a Heart-Healthy Holiday 2Health News:Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy 2Health News:Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy 3Health News:Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry 2Health News:Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry 3Health News:One shot of gene therapy spreads through brain in animal study 2Health News:One shot of gene therapy spreads through brain in animal study 3Health News:QMed, Inc. Reports Third Quarter Results 2Health News:QMed, Inc. Reports Third Quarter Results 3Health News:QMed, Inc. Reports Third Quarter Results 4Health News:QMed, Inc. Reports Third Quarter Results 5Health News:QMed, Inc. Reports Third Quarter Results 6Health News:Lacey Veterinarian Awarded 2007 WSVMA Recent Graduate Award 2
... monoclonal antibody based coagglutination test ... of Neisseria gonorrhoeae. The test ... or fresh cultures. After heating ... rotation, a positive reaction will ...
... test designed specifically for detecting gastric occult ... device. Fecal occult blood tests do ... gastric specimens. This CLIA Waived test ... various gastric conditions which may be encountered ...
... The OcuLight family of infrared laser photocoagulators ... models. These diode lasers serve as a ... and applications, require no regular maintenance or ... their compact design. The OcuLight SLx is ...
... This basic model is the least expensive of the ... endothelium in the central area of the cornea. The ... monitor. ,To take a picture of a patients corneal ... or her chin on the chin rest. The left ...
Medicine Products: